Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Mid-range Performer
1958.9000 -19.20 (-0.97%)
NSE Sep 24, 2025 14:28 PM
Volume: 1,919
 

1958.90
-0.97%

Hester Biosciences Ltd 1QFY17 result update

BOB Capital Markets Ltd.
Hester Biosciences Ltd. posted robust growth in 1QFY17 with revenue growth of 22.8%/6.9% YoY/QoQ, respectively, to Rs 301mn led by 21.6%/41% growth in poultry segment/Large animal segment. EBITDA for the quarter grew by 31%/9.8% YoY/QoQ respectively to Rs 107mn with the expansion in EBITDA margins by 222/94bps YoY/QoQ to 35.5% mainly due to shift in product mix, better inventory management, credit control and lower financing cost.
Hester Biosciences Ltd. has gained 41.03% in the last 6 Months
More from Hester Biosciences Ltd.
Recommended